Radiation Oncology

Wenqing Sun, MD, PhD


Assistant Professor of Radiation Oncology

Contact Information

Email: wenqing-sun@uiowa.edu


MD, Medicine, Peking University Health Science Center
PhD, Free Radical and Radiation Biology, University of Iowa

Residency, Beijng Cancer Hospital, Beijing China
Internship, Internal Medicine, University of Iowa
Residency, Radiation Oncology, University of Iowa

Licensure and Certifications

China Medical License
Iowa Medical License
Passed oral boards
Passed written boards

All Publications

McGuire S, Bhatia S, Sun W, Jacobson G, Menda Y, Ponto L, Smith B, Gross B, Bayouth J, Sunderland J, Graham M, Buatti J.  Using Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients .  Int J Radiat Oncol Biol Phys.  2016 April 19. 

Hoover A, Milhem M, Anderson C, Sun W, Smith B, Hoffman H, Buatti J.  Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.  Head Neck.  2015 May. 37(5):722-6.

Anderson C, Chang T, Graham M, Marquardt M, Button A, Smith B, Menda Y, Sun W, Pagedar N, Buatti  J.  Change of Maximum Standardized Uptake Value Slope in Dynamic Triphasic [(18)F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Distinguishes Malignancy From Postradiation Inflammation in Head-and-Neck Squamous Cell Carcinoma: A Prospective Trial..  Int J Radiat Oncol Biol Phys.  2015 March 1. 91(3):472-9.

Zhang W, Bhatia S, Sun W, Modrick J, Kim Y.  Bladder and rectum dose estimations on digitized radiographs for vaginal brachytherapy after hysterectomy..  J Appl Clin Med Phys.  2014 November 8. 15(6):5033.

Patel S, TenNapel M, Button A, Bhatia S, Sun W.  Impact on survival of brachytherapy in inoperable endometrial cancer: the (SEER) experience from 2004-2010. .  ASTRO 56th Annual Meeting .  2014 September 14. 

Kim Y, Cheung K, Wang D, Mart C, Sheybani A, Sun W, Bhatia S.  Overall rectum and bladder doses when integrated EBRT and HDR brachytherapy doses for cervical cancer by accounting for organ deformations. .  ASTRO 56th Annual Meeting.  2014 September 14. 

Chang T, Anderson C, Marquardt M, Sun W, Graham M, Button A, Buatti  J.  Phase 2 prospective trial of triphasic PET/CT: primary site inflammation versus cancer at 3 months after completion of radiation for head and neck squamous cell carcinoma. .  ASTRO 56th Annual Meeting .  2014 September 14. 

Plichta K, Sun W, Anderson C, Brown B, Casavant T, Braun T, Buatti  J.  The prognosis value of pretreatment FDG-PET in head and neck squamous cell cancers treated with definitive chemoradiation. .  ASTRO 56th Annual Meeting .  2014 September 14. 

McGuire S, Hareendran R, Xia J, Bhatia S, Sun W, Rockey W, Menda Y, Ponto L, Gross B, Buatti  J.  Voxel based analysis of bone marrow response to chemoraradiation therapy using FLT PET images in pelvic cancer patients. .  ASTRO 56th Annual Meeting .  2014 September 14. 

Anderson C, Sun W, Buatti J, Maley J, Policeni B, Mott S, Bayouth J.  Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.  Jacobs J Radiat Oncol.  2014 September. 1(1):006.

Sun W, Zheng B, Lure F, Wu T, Zhang J, Wang B, Saltzstein E, Qian W.  Prediction of near-term risk of developing breast cancer using computerized features from bilateral mammograms..  Comput Med Imaging Graph.  2014 July. 38(5):348-57.

Sheybani A, TenNapel M, Lack W, Clerkin P, Hyer D, Sun W, Jacobson G.  Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysis..  J Radiat Oncol Biol Phys.  2014 July 1. 89(3):584-9.

Li H, Bai J, Wu X, Mart C, Bhatia S, Abu-Hejleh T, Sun W, TenNapel M, McGuire S, Flynn R, Buatti J, Kim  Y.  Semi-Automated Co-Segmentation of Tumor Volume Using Multimodality Pet-Ct in Non-Small Cell Lung Cancer (NSCLC).  Austin J Cancer Clin Research.  2014 May 28. 1(3):1013.

Hoover A, Milhem M, Anderson C, Sun W, Smith B, Hoffman H, Buatti J.  Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma. Results of a phase II clinical trial. .  Head Neck.  2014 March 5. 

Lorenzen A, De Andrade J, Lizarraga I, Scott-Conner C, Sugg S, Erdahl L, Sun W, Weigel R.  Intraoperative Radiotherapy For Breast Cancer Treatment in a Rural Community. .  SSO.  2014. 

Parkhurst J, Erickson S, Wenqing S, Funk G, Anderson C, Buatti J.  Parathyroid Adenoma: Report of a patient successfully treated with stereotactic body radiation therapy..  Pract Radiat Oncol.  2014 January. 4(1):55-7.

Schnidel J, Bhatia S, Sun W, Kim Y.  Dosimetric impacts of applicator displacement and applicator reconstruction -uncertainities on 3D image-guided brachytherapy for cervical cancer. .  J Contemp Brachytherapy .  2013 December. 5(4):250-7.

Anderson C, Marquardt M, Steen S, Hoover A, Button A, Karnell L, Wehbe A, Sun W, Funk G, Buatti J.  Analysis of Pathologic Factors From Surgical Resection Influences Accuracy of 3 Month Post-Radiation Therapy FDG PET/CT in Resected Oral Cavity Cancer Patients.  Int J Radiat Oncol Biol Phys.  2013 October 1. 87(2):S195.

Yang W, Kim Y, Wu X, Song Q, Liu Y, Bhatia S, Sun W, Flynn R.  Rotating-shield brachytherapy for cervical cancer..  Phys Med Biol.  2013 June 7. 58(11):3931-41.

Liu Y, Flynn R, Yang W, Kim Y, Bhatia S, Sun W, Wu X.  Rapid emission angle selection for rotating-shield brachytherapy..  Med Phys.  2013 May. 40(5):051720.

Sun W, Bhatia S, Jacobson G, Flynn R, Kim Y.  Target volume changes through high-dose-rate brachytherapy for cervical cancer when evaluated on high resolution (3.0 Tesla) magnetic resonance imaging. .  Pract Radiat Oncol.  2012 October. 2(4):e101-6.

Bauer C, Sun S, Sun W, Otis J, Wallace A, Graham M, Smith B, Sunderland J, Sonka M, Buatti J, Beichel R.  Automated measurement of uptake in cerebellum, liver, and aortic arch in full-body FDG PET/CT scans. .  Med Phys.  2012 June. 39(6):3112-23.

Sun W, Weydert C, Zhang Y, Xiao L, Spitz D, Domann F, Oberley L.  Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer.  Cancers (Basel).  2010 February 12. 2(1):68-87.

Sun W, Kalen A, Smith B, Cullen J, Oberley L.  Enhancing the antitumor activity of adriamycin and ionizing radiation..  Cancer Res.  2009 May 15. 69(10):4294-300.

Yu L, Hitchler M, Sun W, Sarsour E, Goswami P, Klingelhutz A, Domann F.  AP-2alpha inhibits c-MYC induced oxidative stress and apoptosis in HaCaT human keratinocytes..  J Oncol.  2009. 2009(Article ID 780874).

Weydert C, Zhang Y, Sun W, Waugh T, Teoh M, Andringa K, Aykin-Burns N, Spitz D, Smith B, Oberley L.  Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chlorethyl)-1 nitrosourea) inhibits breast cancer cell growth. .  Free Radic Biol Med.  2008 March 1. 44(5):856-67.

Teoh M, Sun W, Smith B, Oberley L, Cullen J.  Modulation of reactive oxygen species in pancreatic cancer..  Clin Cancer Res.  2007 December 15. 13(24):7441-50.

Liu J, Du J, Zhang Y, Sun W, Smith B, Oberley L, Cullen J.  Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase.  Hum Gene Ther.  2006 January. 17(1):105-16.

Liu J, Hinkhouse M, Sun W, Weydert C, Ritchie J, Oberley L, Cullen J.  Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype.  Hum Gene Ther.  2004 March. 15(3):239-50.

Zhao A, Li J, Sun W.  Detection and significance of lymph node micrometastases in patients with histologically node-negative gastric carcinoma. .  Zhonghua Zhong Liu Za Zhi.  2000 May. 22(3):222-4.

Anderson C, Loth E, Opat E, Bodeker K, Ahmann L, Parkhurst J, Sun W, Furgan M, Laux D, Brown H, Vollstedt S, Follmer K, Ma D, Spitz D, Fath M, Buatti J, Allen B.  A Phase I Trial of Ketogenic Diet with Concurrent Chemoradiation (ChemoRT) in Head and Neck Squamous Cell Carcinoma (HNSCC).  Multidisciplinary Head and Neck Cancer Symposium. February 18-20, 2016. Phoenix, AZ. 

Yuan T, Watkins J, Mott S, Marquardt M, Hoover A, Sun W, Buatti J, Pagedar N, Anderson C.  Does Routine Surveillance PET/CT at 3 Months Have Value After Laryngectomy (L) Followed by Radiotherapy (RT) for Locoregionally Advanced Laryngeal Cancer (LC)?.  Multidisciplinary Head and Neck Cancer Symposium. February 18-20, 2016. Phoenix, AZ. 

Anderson C, Allen B, Sun W, Agarwala S, Kunos C, Venigalla M, Greenberg L, Adkins D, Chen Y, Zhen W, Mould D, Holmulnd J, Brill J, Sonis S, Buatti J.  Phase 1 trial of superoxide (SO) dismutase (SOD) mimetic GC4419 to reduce chemoradiotherapy (CRT)-induced mucositis (OM) in patients (pts) with mouth or oropharyngeal carcinoma (OCC)..  MASCC/ISOO Annual Meeting on Supportive Care in Cancer. Oral Mucositis Workshop. June 25-27, 2015. Copenhagen, Denmark.. 

Anderson C, Allen B,  W, Agarwala S, Lee C, Kunos C, Venigalla M, Greenberg L, Adkins D, Chen Y, Zhen W, Mould D, Holmlund J, Brill J, Sonis S, Buatti J.  Phase 1b trial of superoxide (SO) dismutase (SOD) mimetic GC4419 to reduce chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients (pts) with oral cavity or oropharyngeal carcinoma (OCC) .  ASCO Meeting 2016. 

Anderson C, Allen B, Sun W, Lee C, Agarwala S, Venigalla M, Greenberg L, Adkins D, Chen Y, Zhen W, Mould D, Holmlund J, Brill J, Sonis S, Buatti  J.  Phase 1b/2a Trial of Superoxide (SO) Dismutase (SOD) Mimetic GC4419 to Reduce Cehmoradiotherapy-induced Oral Mucositis (OM) in Patients (pts) With Oral Cavity or Oropharyngeal Carcinoma (OCC).  Multidisciplinary Head and Neck Cancer Symposium. February 18-20, 2016. Phoenix, AZ.. 

Furgan M, Saqlain M, Mott S, Patel R, Laux D, Zhang J, Abushahin L, Anderson C, Watkins J, Snow A, Sun W, Clamon G.  Retrospective comparison between high dose cisplatin & less intensive weekly cisplatin/paclitaxel concurrently with radiation for locally advanced head and neck cancer (LAHNC)..  ASCO Abstract #169346. 

Date Last Modified: 06/06/2016 - 13:17:48